People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

7.70CAD
2:27pm EDT
Price Change (% chg)

$0.10 (+1.32%)
Prev Close
$7.60
Open
$7.48
Day's High
$7.70
Day's Low
$7.27
Volume
1,693
Avg. Vol
2,275
52-wk High
$9.25
52-wk Low
$4.04

Search Stocks

Connop, Bruce 

Brief Biography

Dr. Bruce Connop is Vice President - Non-Clinical & Pharmaceutical Development of Transition Therapeutics Inc. Dr. Connop has been with Transition since 2006 and served as Sr. Director, Nonclinical Drug Development until he was appointed VP, Non-Clinical & Pharmaceutical Development in 2012. With his expertise in pharmacology, toxicology and manufacturing he is responsible for a broad range of activities and has made significant contributions to the advancement of pipeline products. Dr. Connop holds a Ph.D. from Queen’s University and has had experience at other biotech and pharmaceutical companies.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
194,782 -- 92,400 287,182

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

706,308

Nicole Rusaw

316,054

Carl Damiani

319,775

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of 29 Jun 2013
Search Stocks